by Michael May | Aug 30, 2016
Michael May is President and CEO of CCRM, a leader in developing and commercializing regenerative medicine, cell and gene therapy technologies, Michael Rudnicki is Scientific Director and CEO of Stem Cell Network, with a mandate to translate stem cell research into...
by David Brindley | Sep 23, 2014
. With contributions from James Smith, a recent Oxford University graduate and current SENS Research Foundation Summer Scholar working at the Harvard Stem Cell Institute. Assume a single bacterium weighs one thousand billionth of a gram. If it, and each of its...
by Paul Krzyzanowski | Jan 8, 2013
This year, your household will pay $360 for the use of Intellectual Property (IP) held by people and corporations outside of Canada. For a little less than a dollar a day, you’re supporting industries like biotechnology, high-tech electronics, and engineering in other...
by Stacey Johnson | Sep 26, 2012
My grandmother, at 97, is excited about stem cell research because she sees the possibilities. Regenerative medicine IS an exciting field. It’s on the cutting edge of science and fans and critics alike debate its merits regularly in the press and in blogs. Every day,...
Comments